Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidence Critical reviews in...
aprepitant chemo induced n/v IV Emend generic fosaprepitant options for CINV with highly emetic regimens olanzapine + dexamethazone + palonosetron NK-1 inhibitor (-prepitant) + dexamethasone...
what chemo regimens are used 1. cyclophosphamide + TBI 2. Fludarabine + cyclophosphamide + TBI 3. busulfan + cyclophosphamide 4. fludarabine + TBI What toxicity specific to busulfan? prevention? 1....
A new study provides powerful evidence that when it comes to treating cancer, our current chemo regimens may not be the best strategy
Several HAIC regimens have been reported, including cisplatin monotherapy, cisplatin plus 5... We have entered an era of chemo-diversity in the treatment of advanced HCC. This review aimed...
The chemo-immunotherapy (CIT) and chemo-adoptive immunotherapy (CAIT) regimens tested in the past decade are summarized. From them we have learned a great deal about the interactions between variou...
What is chemotherapy? ; Chemotherapy, often called chemo for short, uses medicines to stop or slow the growth of breast cancer cells. Chemotherapy for breast cancer and other cancers is considered systemic therapy because it travels through the bloodstream and affects the whole body. Breast cancer cells grow and divide faster than healthy, normal cells. Chemotherapy affects rapidly dividing cells, such as cancer cells, more than it affects healthy cells. Still, chemotherapy medicines are powerful and can damage healthy cells, especially cells t ...
Chemotherapy regimens for breast cancer can vary wildly in price even when they are comparable in their ability to combat tumors, a U.S. study suggests.
novel chemo-immunotherapy combinations. It also highlights the key determinants of the... Combination regimens may provide a meaningful advantage over monotherapy, by maximizing cancer...
Chellapandian 162 3 376 2013 10.1111/bjh.12386 Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens...